The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A hybrid of the prone and left lateral decubitus positions for thoracoscopic esophagectomy with extended LN dissection for esophageal squamous cell carcinoma.
 
Hirofumi Kawakubo
No Relationships to Disclose
 
Shuhei Mayanagi
No Relationships to Disclose
 
Satoru Matsuda
No Relationships to Disclose
 
Yuko Kitagawa
Honoraria - Asahi Kasei; Asahi Kasei; Asahi Kasei; Asahi Kasei; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Ethicon; Ethicon; Ethicon; Ethicon; Nippon Kayaku; Nippon Kayaku; Nippon Kayaku; Nippon Kayaku; Olympus; Olympus; Olympus; Olympus; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ajinomoto (Inst); Ajinomoto (Inst); Ajinomoto (Inst); Ajinomoto (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); CSL Behring (Inst); CSL Behring (Inst); CSL Behring (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Dainippon Sumitomo Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kowa (Inst); Kowa (Inst); Kowa (Inst); Kureha (Inst); Kureha (Inst); Kureha (Inst); Kureha (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Medicon (Inst); Medicon (Inst); Medicon (Inst); Medicon (Inst); Medtronic (Inst); Medtronic (Inst); Medtronic (Inst); Medtronic (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Shionogi (Inst); Shionogi (Inst); Shionogi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Taisho Toyama Pharma (Inst); Taisho Toyama Pharma (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Teijin Pharma (Inst); Teijin Pharma (Inst); Teijin Pharma (Inst); Teijin Pharma (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst)